Michal Zimmermann

5PUBLICATIONS
45CO-AUTHORS
Metabolomic chemistryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 27, 2026
Structure and mechanism of inhibition of lysine demethylase 2A (KDM2A) by compound 183c.

|Jun 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

|Jan 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.

Ezra Y Rosen, Timothy A Yap, Elisa Fontana

|Aug 06, 2025
The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity.

John Maris, Isabel Soria-Bretones, Matias Casás-Selves

|Feb 20, 2024
Targeting ATR in patients with cancer.

Natalie Y L Ngoi, Patrick G Pilié, Daniel J McGrail

Pageof 1

Frequent Collaborators

2 joint publications

Timothy A Yap

2 joint publications

John Maris

2 joint publications

David Groff

2 joint publications

Jamie I Fletcher